ArticleNature communications2025
Site-specific synergy by heteronuclear microenvironment atomic editing for oxygen reduction reaction.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Vapor-Depositing Single-Atom Iron Catalysts on Porous Carbon Nanosheets for Enhanced Oxygen Reduction.Small (Weinheim an der Bergstrasse, Germany) · 2026Article
- RuNature communications · 2026Article
- Synergistic Charge Redistribution in a Dual-Atomic Fe-CoNSmall (Weinheim an der Bergstrasse, Germany) · 2026Article
- WAngewandte Chemie (International ed. in English) · 2026Article
- Selective Functionalization with Organophosphite Ligands of Atomically Precise Platinum Chini Clusters.Inorganic chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Although iron-nitrogen-carbon catalysts are appealing for use in the oxygen reduction reaction, achieving high activity and a long lifetime remains a persistent challenge. This necessitates the precise modulation of the active sites' microenvironment. Herein, we present a microenvironment atomic editing strategy for accessing heteronuclear triatomic Fe and Co sites of Fe
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.